Semax (ACTH Fragment Peptide)
A Mechanism Layer Below Gene Expression
Kolbaev and colleagues examined the effect of Semax on intracellular calcium dynamics in rat brain neurons, published in the Bulletin of Experimental Biology and Medicine in August 2025 — a different and faster level of mechanism than the neurotrophin expression literature.
Key facts
- Study
- Kolbaev 2025 (PMID 41171324)
- Journal
- Bull Exp Biol Med, August 2025
- Preparation
- Rat brain neurons
- Measured
- Intracellular calcium dynamics
- Timescale
- Seconds to minutes
- Contrast
- Gene expression acts over hours
Why calcium is a useful readout
Intracellular calcium concentration is one of the most general signalling variables a neuron has. It changes within seconds of a stimulus, it is measurable in living cells with fluorescent indicators, and it sits upstream of a great many downstream processes. A compound that alters calcium dynamics is doing something at the level of immediate cell signalling.
Why this differs from the neurotrophin work
The existing Semax literature centres on expression of neurotrophins such as BDNF and NGF — a transcriptional readout operating over hours. Calcium operates over seconds. These are not competing accounts; they are different levels of a potential causal chain, and a fast signalling event is the kind of thing that could sit upstream of a slower transcriptional one.
Research material referenced
Semax 10mg — third-party HPLC tested
Why a fast readout is analytically valuable
Expression changes measured hours after exposure leave a long interval in which many things could intervene. An effect appearing within seconds in isolated neurons is much harder to attribute to anything other than the compound present, which narrows the causal question considerably even without identifying a receptor.
What it does not establish
A receptor, or a behavioural consequence. Altered calcium dynamics in rat brain neurons is a cellular observation. Semax still has no identified receptor, and a calcium effect is compatible with several mechanisms including indirect ones. It narrows the question rather than answering it.
Where the publication sits
The Bulletin of Experimental Biology and Medicine is a Russian journal, and the Semax literature is substantially Russian in origin — a point the existing literature article on this site makes. That is context for interpretation rather than a dismissal: the language and location of publication are not measures of quality, and limited independent replication outside that tradition is a genuine and separate limitation.
Regulatory position
Semax holds no marketing authorisation from the MHRA, EMA or FDA. Registration in another jurisdiction does not alter that, and material supplied here is for laboratory research only with no claim about any effect in any person.
Extended research context
The Semax (ACTH Fragment Peptide) deep dive
Deep dive: what the Pro-Gly-Pro extension actually accomplishes
Semax is built from a four-residue fragment of ACTH with Pro-Gly-Pro appended, and that appendix does two separate jobs at once. Proline is the only proteinogenic amino acid whose side chain bonds back to its own backbone nitrogen, forming a ring that removes the amide hydrogen and locks rotation. Proteolytic enzymes generally need an extended, rotatable backbone at their active site, so bonds near proline are poor substrates for most of them — which is why proline-rich motifs recur throughout stabilised peptide design. The second job is subtractive: Pro-Gly-Pro occupies the positions where ACTH carries Arg-Trp-Gly, and those are the residues contributing to the parent hormone's adrenal-stimulating activity. One substitution therefore buys protease resistance and removes an unwanted pharmacology, which is unusually economical design.
Deep dive: the naming point worth getting right
Semax is near-universally described as an ACTH(4-10) analogue, and peer-reviewed paper titles use that phrase. Structurally it is not quite that. ACTH residues 4 to 10 are Met-Glu-His-Phe-Arg-Trp-Gly; Semax is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues match and the last three are wholly different — replacement rather than modification. PubChem, indexing by structure rather than design lineage, records it as ACTH(4-7) plus Pro-Gly-Pro. Neither name is wrong, but the loose one obscures the fact that the substituted segment is precisely the functionally consequential part.
Deep dive: reading an unevenly distributed evidence base
Semax's roughly 231 indexed records split along an unusual line. Mechanistic work — BDNF and trkB expression in rat hippocampus, transcriptomics in focal cerebral ischaemia, neurotrophin dynamics across brain regions — appears in international journals in English and can be assessed directly. Clinical work is concentrated in Russian-language publications, principally the Korsakov Journal of Neurology and Psychiatry, indexed by translated title and often without accessible English full text, much of it predating current standards for pre-registration and reporting. The honest position is that this is evidence which is difficult to verify independently, which is a different thing from evidence that is absent, and a different thing again from evidence that is established.
Research applications
- ▸Neurotrophin expression research (BDNF, NGF, TrkB, TrkA)
- ▸Neuroprotection and cerebral ischaemia models
- ▸Study of proline-stabilised peptide design
- ▸Comparative work on ACTH fragments without steroidogenic activity
- ▸Transcriptomic profiling in rodent brain models
Handling checklist
- ✓Store lyophilised material cold, dry and protected from light
- ✓Expect methionine oxidation as the degradation route (+16 Da; only one Met, so not +32)
- ✓No reducing agent needed — the sequence contains no cysteine
- ✓Introduce diluent gently against the vial wall; swirl rather than shake
- ✓Aliquot to avoid repeated freeze-thaw cycles
- ✓Check whether a certificate reports net peptide content or gross salt weight
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Describing Semax as ACTH(4-10) without qualification
Fix: It shares only residues 4-7; Pro-Gly-Pro replaces Arg-Trp-Gly, and that replacement is the design's whole point.
✗ Treating Russian registration as equivalent to MHRA approval
Fix: Authorisations are jurisdictional and do not transfer. Semax has never been assessed by the MHRA, EMA or FDA.
✗ Reading a BDNF expression change as a demonstrated outcome
Fix: The studies measured gene and protein expression in rats. Expression is upstream of function and upstream again of any clinical claim.
✗ Assuming a named receptor exists
Fix: No primary receptor has been definitively established; the literature characterises downstream effects more confidently than the initiating event.
✗ Expecting ACTH-like adrenal effects
Fix: Semax does not stimulate adrenal steroidogenesis — the responsible residues were substituted out.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- What is Semax?
- Is Semax really an ACTH(4-10) analogue?
- How does Semax affect BDNF?
- What are glyprolines?
- Is Semax approved in the UK?
- How does Semax differ from Selank?
Frequently asked questions
- What did the 2025 study measure?
- Intracellular calcium dynamics in rat brain neurons following Semax exposure — a cellular signalling readout.
- How does that relate to the BDNF work?
- Different timescales. Calcium changes within seconds; gene expression over hours. A fast event could sit upstream of a slower transcriptional one.
- Does it identify a receptor?
- No. Semax still has no identified receptor, and a calcium effect is compatible with several mechanisms including indirect ones.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedKolbaev SN et al., The Effect of Peptide Semax, an ACTH(4-10) Analogue, on Intracellular Calcium Dynamics in Rat Brain Neurons — Bull Exp Biol Med 2025 (PMID 41171324)pubmed.ncbi.nlm.nih.gov
- PubMedGlazova NY et al., Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations — Neuropeptides 2021 (PMID 33418449)pubmed.ncbi.nlm.nih.gov
- PubMedSemax, an analog of ACTH(4-10), regulates BDNF and trkB expression — Brain Res 2006 (PMID 16996037)pubmed.ncbi.nlm.nih.gov
- PubMedThe heptapeptide SEMAX stimulates BDNF expression in rat brain — Dokl Biol Sci 2003 (PMID 14556513)pubmed.ncbi.nlm.nih.gov
- PubMedTemporal dynamics of NGF and BDNF gene expression — J Mol Neurosci 2010 (PMID 19662538)pubmed.ncbi.nlm.nih.gov
- PubMedSemax affects immune and vascular gene expression in rat focal ischaemia — BMC Genomics 2014 (PMID 24661604)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · Semax (CID 9811102)pubchem.ncbi.nlm.nih.gov
- PubChemPubChem · Semax acetate (CID 155977617)pubchem.ncbi.nlm.nih.gov
- RefMHRA — Medicines and Healthcare products Regulatory Agencygov.uk
- GuidelineGoogle — Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
Jack Muncaster · Founder, UK Peptides
Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.
More Semax (ACTH Fragment Peptide) articles
- What the Animal Behavioural Work ReportsGlazova 2021 examined Semax against alterations following early-life fluvoxamine exposure in rats. Why the model design is the interesting part.
- What a Fragment Keeps Decides What It DoesThree fragments of alpha-MSH pursue pigmentation, inflammation and cognition. The difference is not the parent — it is which residues each retained.
- What Is Semax? A Complete Research OverviewSemax is a synthetic heptapeptide derived from an ACTH fragment, developed in Russia. Structure, neurotrophin mechanism, regulatory status and the evidence base.
- Is Semax Really an ACTH(4-10) Analogue?Semax is universally called an ACTH(4-10) analogue, but shares only residues 4-7 with ACTH. Pro-Gly-Pro replaces Arg-Trp-Gly, and that substitution is the point.
- Semax Structure, Sequence and Physical PropertiesSemax is MEHFPGP, 7 residues, 813.9 Da, C37H51N9O10S. Sequence features, the two prolines, the single methionine, and what each means for handling.
Popular across the research hub
One flagship guide from every other research category — keep exploring.
- Retatrutide ResearchWho Develops Retatrutide?
- GHK-Cu (Copper Peptide)The Molecular Structure of GHK and Its Copper Complex
- TB-500 (Thymosin β4 fragment)TB-500 Half-Life and Clearance
- BPC-157 (Pentadecapeptide)Body Protection Compound: A Name That Is a Hypothesis
- CJC-1295 & IpamorelinWhat Is a Growth Hormone Secretagogue?
- Peptide ReferenceLyophilisation: Why Peptides Arrive as Powder
- Bacteriostatic WaterBacteriostatic Water vs Bacteriostatic Sodium Chloride
- Research & Regulatory NewsWhy Peptides Cannot Normally Be Taken Orally
- GLP-1 & Incretin ScienceA Third Way an Adverse Effect Can Arise
- MOTS-c (Mitochondrial Peptide)Why Mitochondrial Genetics Is Not Like Nuclear Genetics
- Selank (Tuftsin Analogue)Tuftsin and the Antigenicity Question
- DSIP (Delta Sleep-Inducing Peptide)The Missing Biology: No Gene, No Precursor, No Receptor
- KLOW (Blend)The Fourth Component: What KPV Actually Adds
- GLOW (Blend)Why the Copper Question Has a Good Answer Here
- MT-2 (Melanotan II)Five Melanocortin Receptors, Not One
- IGF-1 LR3Recombinant Versus Synthetic: Two Different Quality Problems
- GlutathioneGSH and GSSG: What the Ratio Measures
- NAD+The Membrane Problem: Why NAD+ Doesn't Get In
- KPVAlpha-MSH: Pigmentation and Inflammation in One Hormone